BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15387095)

  • 1. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ allocation for liver-intestine candidates.
    Horslen S
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S86-9. PubMed ID: 15382223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New national liver transplant allocation policy: is the regional review board process fair?
    Voigt MD; Zimmerman B; Katz DA; Rayhill SC
    Liver Transpl; 2004 May; 10(5):666-74. PubMed ID: 15108259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation.
    Nativi JN; Kfoury AG; Myrick C; Peters M; Renlund D; Gilbert EM; Bader F; Singhal AK; Everitt M; Fisher P; Bull DA; Selzman C; Stehlik J
    J Heart Lung Transplant; 2010 Mar; 29(3):235-9. PubMed ID: 19782588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for liver transplantation waiting list mortality.
    Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
    J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Child-Turcotte-Pugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation.
    Dehghani SM; Gholami S; Bahador A; Haghighat M; Imanieh MH; Nikeghbalian S; Salahi H; Davari HR; Mehrabani D; Malek-Hosseini SA
    Transplant Proc; 2007 Dec; 39(10):3175-7. PubMed ID: 18089346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the futile pediatric liver re-transplant in the PELD era.
    Lao OB; Dick AA; Healey PJ; Perkins JD; Reyes JD
    Pediatr Transplant; 2010 Dec; 14(8):1019-29. PubMed ID: 21108708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of thoracic organ transplantation and allocation in the United States.
    Coke M; Edwards LB
    Clin Transpl; 2004; ():17-26. PubMed ID: 16704135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.